Skip to content
Catalyst

Ginkgo bilobaFinding

Ginkgo biloba increases clinical effective rate (composite responder rate)

raisesModerate evidenceFinding

01 · The sentence it was drawn from

“The patients in the experimental group showed a higher total effective rate than those in the control group (RR = 1.21, 95% CI: 1.17–1.26, p < 0.00001).”
Quoted verbatim from Efficacy and safety of Ginkgo biloba extract as an adjuvant in the treatment of Chinese patients with sudden hearing loss: a meta-analysis.
This finding among the 2 findings on its endpoint

Ginkgo biloba

Clinical effective rate (composite responder rate)

raises

Effect as reported

1.21risk ratio

CI 1.17 to 1.26

Who
Patients with sudden hearing loss; 27 pooled randomised trials, Ginkgo biloba extract plus general treatment against general treatment alone
Dose studied
70 to 140 mg/day in most trials, courses of 10 or 14 days

Moderate evidencePMID 36999358 · 2023

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Pharmaceutical biology
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZB24C86GRCKZ3A2YMZ700J